Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
36
MEDX Quote, Financials, Valuation and Earnings
Last price:
$33.50
Seasonality move
:
3.14%
Day range:
$33.42 - $33.52
52-week range:
$23.46 - $34.09
Dividend yield:
1.37%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
843
Avg. volume:
732
1-year change:
18.82%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MEDX
Horizon Kinetics Medical ETF
|
$33.50 | -- | -- | -- | $0.51 | 1.37% | -- |
|
AGNG
Global X Aging Population ETF
|
$36.31 | -- | -- | -- | $0.14 | 0.79% | -- |
|
HRTS
Tema Heart & Health ETF
|
$35.35 | -- | -- | -- | $0.47 | 0.4% | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
$58.01 | -- | -- | -- | $0.33 | 4.86% | -- |
|
PPH
VanEck Pharmaceutical ETF
|
$99.61 | -- | -- | -- | $0.39 | 1.94% | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
$25.22 | -- | -- | -- | $0.22 | 0.87% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MEDX
Horizon Kinetics Medical ETF
|
-- | 0.449 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 0.484 | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | 0.753 | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | 0.523 | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | 0.233 | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | 0.787 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | -- | -- | -- | -- | -- |
Horizon Kinetics Medical ETF vs. Competitors
-
Which has Higher Returns MEDX or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Horizon Kinetics Medical ETF's net margin of --. Horizon Kinetics Medical ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MEDXHorizon Kinetics Medical ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About MEDX or AGNG?
Horizon Kinetics Medical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Horizon Kinetics Medical ETF has higher upside potential than Global X Aging Population ETF, analysts believe Horizon Kinetics Medical ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings MEDXHorizon Kinetics Medical ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is MEDX or AGNG More Risky?
Horizon Kinetics Medical ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.743, suggesting its less volatile than the S&P 500 by 25.722%.
-
Which is a Better Dividend Stock MEDX or AGNG?
Horizon Kinetics Medical ETF has a quarterly dividend of $0.51 per share corresponding to a yield of 1.37%. Global X Aging Population ETF offers a yield of 0.79% to investors and pays a quarterly dividend of $0.14 per share. Horizon Kinetics Medical ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDX or AGNG?
Horizon Kinetics Medical ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Horizon Kinetics Medical ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Horizon Kinetics Medical ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Horizon Kinetics Medical ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDXHorizon Kinetics Medical ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns MEDX or HRTS?
Tema Heart & Health ETF has a net margin of -- compared to Horizon Kinetics Medical ETF's net margin of --. Horizon Kinetics Medical ETF's return on equity of -- beat Tema Heart & Health ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MEDXHorizon Kinetics Medical ETF-- -- -- HRTSTema Heart & Health ETF-- -- -- -
What do Analysts Say About MEDX or HRTS?
Horizon Kinetics Medical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Heart & Health ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Horizon Kinetics Medical ETF has higher upside potential than Tema Heart & Health ETF, analysts believe Horizon Kinetics Medical ETF is more attractive than Tema Heart & Health ETF.
Company Buy Ratings Hold Ratings Sell Ratings MEDXHorizon Kinetics Medical ETF0 0 0 HRTSTema Heart & Health ETF0 0 0 -
Is MEDX or HRTS More Risky?
Horizon Kinetics Medical ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema Heart & Health ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MEDX or HRTS?
Horizon Kinetics Medical ETF has a quarterly dividend of $0.51 per share corresponding to a yield of 1.37%. Tema Heart & Health ETF offers a yield of 0.4% to investors and pays a quarterly dividend of $0.47 per share. Horizon Kinetics Medical ETF pays -- of its earnings as a dividend. Tema Heart & Health ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDX or HRTS?
Horizon Kinetics Medical ETF quarterly revenues are --, which are smaller than Tema Heart & Health ETF quarterly revenues of --. Horizon Kinetics Medical ETF's net income of -- is lower than Tema Heart & Health ETF's net income of --. Notably, Horizon Kinetics Medical ETF's price-to-earnings ratio is -- while Tema Heart & Health ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Horizon Kinetics Medical ETF is -- versus -- for Tema Heart & Health ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDXHorizon Kinetics Medical ETF-- -- -- -- HRTSTema Heart & Health ETF-- -- -- --
-
Which has Higher Returns MEDX or JDOC?
JPMorgan Healthcare Leaders ETF has a net margin of -- compared to Horizon Kinetics Medical ETF's net margin of --. Horizon Kinetics Medical ETF's return on equity of -- beat JPMorgan Healthcare Leaders ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MEDXHorizon Kinetics Medical ETF-- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- -
What do Analysts Say About MEDX or JDOC?
Horizon Kinetics Medical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand JPMorgan Healthcare Leaders ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Horizon Kinetics Medical ETF has higher upside potential than JPMorgan Healthcare Leaders ETF, analysts believe Horizon Kinetics Medical ETF is more attractive than JPMorgan Healthcare Leaders ETF.
Company Buy Ratings Hold Ratings Sell Ratings MEDXHorizon Kinetics Medical ETF0 0 0 JDOCJPMorgan Healthcare Leaders ETF0 0 0 -
Is MEDX or JDOC More Risky?
Horizon Kinetics Medical ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison JPMorgan Healthcare Leaders ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MEDX or JDOC?
Horizon Kinetics Medical ETF has a quarterly dividend of $0.51 per share corresponding to a yield of 1.37%. JPMorgan Healthcare Leaders ETF offers a yield of 4.86% to investors and pays a quarterly dividend of $0.33 per share. Horizon Kinetics Medical ETF pays -- of its earnings as a dividend. JPMorgan Healthcare Leaders ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDX or JDOC?
Horizon Kinetics Medical ETF quarterly revenues are --, which are smaller than JPMorgan Healthcare Leaders ETF quarterly revenues of --. Horizon Kinetics Medical ETF's net income of -- is lower than JPMorgan Healthcare Leaders ETF's net income of --. Notably, Horizon Kinetics Medical ETF's price-to-earnings ratio is -- while JPMorgan Healthcare Leaders ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Horizon Kinetics Medical ETF is -- versus -- for JPMorgan Healthcare Leaders ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDXHorizon Kinetics Medical ETF-- -- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- --
-
Which has Higher Returns MEDX or PPH?
VanEck Pharmaceutical ETF has a net margin of -- compared to Horizon Kinetics Medical ETF's net margin of --. Horizon Kinetics Medical ETF's return on equity of -- beat VanEck Pharmaceutical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MEDXHorizon Kinetics Medical ETF-- -- -- PPHVanEck Pharmaceutical ETF-- -- -- -
What do Analysts Say About MEDX or PPH?
Horizon Kinetics Medical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Pharmaceutical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Horizon Kinetics Medical ETF has higher upside potential than VanEck Pharmaceutical ETF, analysts believe Horizon Kinetics Medical ETF is more attractive than VanEck Pharmaceutical ETF.
Company Buy Ratings Hold Ratings Sell Ratings MEDXHorizon Kinetics Medical ETF0 0 0 PPHVanEck Pharmaceutical ETF0 0 0 -
Is MEDX or PPH More Risky?
Horizon Kinetics Medical ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison VanEck Pharmaceutical ETF has a beta of 0.549, suggesting its less volatile than the S&P 500 by 45.102%.
-
Which is a Better Dividend Stock MEDX or PPH?
Horizon Kinetics Medical ETF has a quarterly dividend of $0.51 per share corresponding to a yield of 1.37%. VanEck Pharmaceutical ETF offers a yield of 1.94% to investors and pays a quarterly dividend of $0.39 per share. Horizon Kinetics Medical ETF pays -- of its earnings as a dividend. VanEck Pharmaceutical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDX or PPH?
Horizon Kinetics Medical ETF quarterly revenues are --, which are smaller than VanEck Pharmaceutical ETF quarterly revenues of --. Horizon Kinetics Medical ETF's net income of -- is lower than VanEck Pharmaceutical ETF's net income of --. Notably, Horizon Kinetics Medical ETF's price-to-earnings ratio is -- while VanEck Pharmaceutical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Horizon Kinetics Medical ETF is -- versus -- for VanEck Pharmaceutical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDXHorizon Kinetics Medical ETF-- -- -- -- PPHVanEck Pharmaceutical ETF-- -- -- --
-
Which has Higher Returns MEDX or THNR?
Amplify Weight Loss Drug & Treatment ETF has a net margin of -- compared to Horizon Kinetics Medical ETF's net margin of --. Horizon Kinetics Medical ETF's return on equity of -- beat Amplify Weight Loss Drug & Treatment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MEDXHorizon Kinetics Medical ETF-- -- -- THNRAmplify Weight Loss Drug & Treatment ETF-- -- -- -
What do Analysts Say About MEDX or THNR?
Horizon Kinetics Medical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Amplify Weight Loss Drug & Treatment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Horizon Kinetics Medical ETF has higher upside potential than Amplify Weight Loss Drug & Treatment ETF, analysts believe Horizon Kinetics Medical ETF is more attractive than Amplify Weight Loss Drug & Treatment ETF.
Company Buy Ratings Hold Ratings Sell Ratings MEDXHorizon Kinetics Medical ETF0 0 0 THNRAmplify Weight Loss Drug & Treatment ETF0 0 0 -
Is MEDX or THNR More Risky?
Horizon Kinetics Medical ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Amplify Weight Loss Drug & Treatment ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MEDX or THNR?
Horizon Kinetics Medical ETF has a quarterly dividend of $0.51 per share corresponding to a yield of 1.37%. Amplify Weight Loss Drug & Treatment ETF offers a yield of 0.87% to investors and pays a quarterly dividend of $0.22 per share. Horizon Kinetics Medical ETF pays -- of its earnings as a dividend. Amplify Weight Loss Drug & Treatment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDX or THNR?
Horizon Kinetics Medical ETF quarterly revenues are --, which are smaller than Amplify Weight Loss Drug & Treatment ETF quarterly revenues of --. Horizon Kinetics Medical ETF's net income of -- is lower than Amplify Weight Loss Drug & Treatment ETF's net income of --. Notably, Horizon Kinetics Medical ETF's price-to-earnings ratio is -- while Amplify Weight Loss Drug & Treatment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Horizon Kinetics Medical ETF is -- versus -- for Amplify Weight Loss Drug & Treatment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDXHorizon Kinetics Medical ETF-- -- -- -- THNRAmplify Weight Loss Drug & Treatment ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 65.44% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 8.33% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 5.85% over the past day.
